title: Muscular dystrophy drug looks set for commercial success despite clinical doubts.
authors.affiliation: Montreal.
authors.forename: Owen
authors.initials: O
authors.lastname: Dyer
mesh_terms: D001291:Attitude of Health Personnel; D017326:Clinical Trials, Phase III as Topic / Q000592:standards; D034462:Dissent and Disputes; D017277:Drug Approval; D016527:Drug Costs; D006801:Humans; D060172:Morpholinos / Q000191:economics / Q000627:therapeutic use*; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy*; D009462:Neurology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D060172:Morpholinos; C000611335:eteplirsen